4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001209191-23-034850
Options or other derivatives
- Director acquired 5,681 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Saad Mark E Director | 2023-06-02 | Grant or award · Stock Option (Right to Buy) | +5,681 | 5,681 | D | ||
Loading xslF345X04/doc4.xml…